Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Zonisade™ (zonisamide) – New drug approval
July 18, 2022 - Azurity Pharmaceuticals announced the FDA approval of Zonisade (zonisamide), as adjunctive therapy for the treatment of partial-onset seizures in adults and pediatric patients 16 years and older.
